Tonix Pharmaceuticals Holding Corp.
Clinical-stage biopharma developing therapeutics for CNS, immune, and infectious diseases.
TNXP | US
Overview
Corporate Details
- ISIN(s):
- US8902608392
- LEI:
- Country:
- United States of America
- Address:
- 26 MAIN STREET, SUITE 101, 7928 CHATHAM
- Website:
- https://www.tonixpharma.com/
- Sector:
- Manufacturing
Description
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company developing therapeutics and vaccines for human diseases. The company's pipeline addresses complex, chronic conditions in several key areas: central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Key CNS programs target conditions such as acute stress disorder. The immunology portfolio includes candidates for preventing organ transplant rejection, managing autoimmune conditions, and immuno-oncology. Its infectious disease efforts focus on biodefense, utilizing a live virus vaccine platform to develop vaccines for mpox and smallpox. The company is also advancing treatments for rare diseases like Prader-Willi Syndrome. All of Tonix's product candidates are investigational and have not been approved for any indication.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-31 17:10 | English | ZIP • 12.2 KB | |||
| 2025-12-29 22:44 |
CURRENT REPORT
|
English | ZIP • 471.2 KB | ||
| 2025-12-29 22:42 |
PROSPECTUS SUPPLEMENT
|
English | ZIP • 160.7 KB | ||
| 2025-12-29 13:45 |
CURRENT REPORT
|
English | ZIP • 125.3 KB | ||
| 2025-12-16 13:05 |
CURRENT REPORT
|
English | ZIP • 103.6 KB | ||
| 2025-12-09 13:33 |
CURRENT REPORT
|
English | ZIP • 121.4 KB | ||
| 2025-11-24 13:06 |
CURRENT REPORT
|
English | ZIP • 126.6 KB | ||
| 2025-11-21 22:48 |
PROSPECTUS SUPPLEMENT
|
English | ZIP • 49.6 KB | ||
| 2025-11-21 22:48 |
CURRENT REPORT
|
English | ZIP • 109.8 KB | ||
| 2025-11-18 23:21 |
CURRENT REPORT
|
English | ZIP • 66.2 KB | ||
| 2025-11-17 13:05 |
CURRENT REPORT
|
English | ZIP • 110.1 KB | ||
| 2025-11-10 22:30 |
QUARTERLY REPORT
|
English | ZIP • 1.6 MB | ||
| 2025-11-10 22:26 |
CURRENT REPORT
|
English | ZIP • 129.9 KB | ||
| 2025-10-31 16:31 | English | ZIP • 8.2 KB | |||
| 2025-10-27 12:00 |
CURRENT REPORT
|
English | ZIP • 71.1 KB |
Automate Your Workflow. Get a real-time feed of all Tonix Pharmaceuticals Holding Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tonix Pharmaceuticals Holding Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tonix Pharmaceuticals Holding Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
